In the fight to save lives against #SARSCoV2#Coronavirus infection, #ECMO offers hope when MV isn’t enough: years of tinkering, decades until acceptance... “It doesn’t treat patient, but it buys time” said Prof Robert Bartlett @ECMO_Bob pioneer of #ECLS https://t.co/55uqrKubD0
CARDS #COVID19#ARDS: unique injury, diffuse micro/macrothromboses, severe endothelial damage disrupting vasoregulation; categorize as L vs H phenotype as different MV needed; cautious weaning for both & be careful with vascular side #COVIDFOAM + podcast https://t.co/zMrOLIwlKy
#ECMOCARD is uniting 120 centres across 26 countries.
As prof. Fraser mentions, there is no textbook or journal to guide us on #COVIDー19 , but with support we are on our way of creating these and more.
@who@ELSOOrg@FOAMecmo @UQMedicine @APELSOorg
https://t.co/wr1lMxZZpC
During these times, we must work together and not against each other.
Here are the facts:
-There is no food shortage & stores will restock, so please don’t hoard.
-The water supply is clean & safe to drink, so there’s no need to buy water in bulk.
-We are in this together.
Congratulazioni Veila, una spiegazione molto istruttiva e interessante di come i social media possono essere usati per migliorare le pubblicazioni mediche tradizionali. Grazie !! @FOAMecmo, #ELSO2019
An international survey of 253 participants showing effects of case mix, clinical experience and ECMO volume in weaning VV ECMO and IMV presented at #ELSO2019, Austin, Tx. Survey lead by Dr. Swol. @ECMOdaily@ELSOOrg@EuroELSO@asaiojournal @HeadRNColumbia @NYPCUCVI @nyphospital